These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1388653)

  • 21. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enzyme defects and primary immunodeficiencies (author's transl)].
    Ito K
    Rinsho Byori; 1979 Dec; 27(12):1075-8. PubMed ID: 120452
    [No Abstract]   [Full Text] [Related]  

  • 23. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 24. Inherited biochemical defects in lymphocytes causing immunodeficiency disease.
    Giblett ER
    Prog Clin Biol Res; 1981; 58():123-34. PubMed ID: 6267616
    [No Abstract]   [Full Text] [Related]  

  • 25. Defects in cell-mediated immunity.
    Rosen FS
    Clin Immunol Immunopathol; 1986 Oct; 41(1):1-7. PubMed ID: 3091306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide-metabolizing enzymes and lymphocyte differentiation.
    Barton RW; Goldschneider I
    Mol Cell Biochem; 1979 Dec; 28(1-3):135-47. PubMed ID: 231199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 28. High risk screening of adenosine deaminase and purine nucleoside phosphorylase deficiency in Japan.
    Kishi T; Sakura N; Ito K; Usui T
    Acta Paediatr Jpn; 1987 Feb; 29(1):152-4. PubMed ID: 3144840
    [No Abstract]   [Full Text] [Related]  

  • 29. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited immunodeficiency diseases: relationship to lymphocyte metabolic dysfunction.
    Giblett ER; Polmar SH
    Prog Med Genet; 1979; 3():177-219. PubMed ID: 118484
    [No Abstract]   [Full Text] [Related]  

  • 31. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Adv Exp Med Biol; 1984; 165 Pt B():133-9. PubMed ID: 6426261
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.
    Maddocks JL; Al-Safi SA; Wilson G
    J Clin Pathol; 1984 Nov; 37(11):1305-7. PubMed ID: 6438186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The origin of human NK cells. An ontogenic model derived from studies in patients with immunodeficiencies.
    Peter HH
    Blut; 1983 May; 46(5):239-48. PubMed ID: 6404329
    [No Abstract]   [Full Text] [Related]  

  • 36. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined immunodeficiency and thymic abnormalities.
    Webster AD
    J Clin Pathol Suppl (R Coll Pathol); 1979; 13():10-4. PubMed ID: 42651
    [No Abstract]   [Full Text] [Related]  

  • 38. Defects of purine metabolism in immunodeficiency diseases.
    Hirschhorn R
    Prog Clin Immunol; 1977; 3():67-83. PubMed ID: 405713
    [No Abstract]   [Full Text] [Related]  

  • 39. Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function.
    Gelfand EW; Dosch HM; Biggar WD; Fox IH
    J Clin Invest; 1978 Apr; 61(4):1071-80. PubMed ID: 96131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune deficiency states: inborn errors of metabolism.
    Pollara B; South MA
    Cutis; 1978 Aug; 22(2):147-50, 155. PubMed ID: 99289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.